Initial Therapeutics
CA - South SFBiotechnology
Focus: Initial Therapeutics is a South San Francisco-based biotech company focused on a selective termination of protein synthesis platform technology. Limited public data suggests early-stage positioning with proprietary technology as core asset.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Initial Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Initial Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Heat Tolerance Assessment
Exertional Heat IllnessClinical Trials (1)
NCT05303142Comparing Exertional Heat Illness Risk Factors Between Patients and Controls
N/AHelp build intelligence for Initial Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.